Newborn screening in mucopolysaccharidoses

Newborn screening (NBS) methods and therapeutic options have become increasingly available for mucopolysaccharidoses (MPS), and there is a clear evidence that early intervention significantly improves the outcome. It is recommended that mucopolysaccharidosis type I (MPS I) is included in the US newb...

Descripción completa

Detalles Bibliográficos
Autores principales: Donati, Maria Alice, Pasquini, Elisabetta, Spada, Marco, Polo, Giulia, Burlina, Alberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6238254/
https://www.ncbi.nlm.nih.gov/pubmed/30442156
http://dx.doi.org/10.1186/s13052-018-0552-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6238254/
https://www.ncbi.nlm.nih.gov/pubmed/30442156
http://dx.doi.org/10.1186/s13052-018-0552-3

Ejemplares similares